Renaissance Technologies's ARKG Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 83,300 shares of ARK Genomic Revolution ETF (ARKG) worth $2.31 M, representing 0.00% of the portfolio. First purchased in 2021-Q4, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in ARKG, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 65,500 shares. Largest reduction occurred in Q3 2022, reducing 39,800 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's ARK Genomic Revolution ETF (ARKG) Holding Value Over Time
Track share changes against reported price movement
Quarterly ARK Genomic Revolution ETF (ARKG) Trades by Renaissance Technologies
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2021 | +41,400 | New Buy | 41,400 | $61.23 |
| Q1 2022 | +16,200 | Add 39.13% | 57,600 | $45.94 |
| Q2 2022 | -57,600 | Sold Out | 57,600 | $0.00 |
| Q3 2022 | +17,800 | New Buy | 17,800 | $32.87 |
| Q4 2022 | -17,800 | Sold Out | 17,800 | $0.00 |
| Q3 2025 | +83,300 | New Buy | 83,300 | $27.77 |
Renaissance Technologies's ARK Genomic Revolution ETF Investment FAQs
Renaissance Technologies first purchased ARK Genomic Revolution ETF (ARKG) in Q4 2021, acquiring 41,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held ARK Genomic Revolution ETF (ARKG) for 16 quarters since Q4 2021. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's largest addition to ARK Genomic Revolution ETF (ARKG) was in Q3 2025, adding 83,300 shares worth $2.31 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 83,300 shares of ARK Genomic Revolution ETF (ARKG), valued at approximately $2.31 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, ARK Genomic Revolution ETF (ARKG) represents approximately 0.00% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's peak holding in ARK Genomic Revolution ETF (ARKG) was 83,300 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.